North American Science Associates Inc.(NAMSA )

ExtheridHuman Skin

SHARE

We use our human skin model to test lead formulations and screen them against a variety of parameters in human skin to ensure clinical success. We perform antimicrobial efficacy testing, biomarker assessments, and host cell toxicity on wounded or unwounded skin.

Most popular related searches
  • To assess inflammation we treat and incubate intact skin, take biopsies from the treated intact skin, and then perform ELISAs or cytokine panel assays to determine quantities of biomarkers.  
  • To test for efficacy against known human pathogens, experiments are typically performed on wounded skin explants. These explants are prepared by removing a small amount of epidermis from the center of a larger explant. The depth and size of these explants and wounds are customizable.
  • We also assess wound healing in the wounded skin model. At specific timepoints post-treatment, we analyze the biomarkers present in wounds and couple that data with histology.